Clinical Trial Update: Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for tifacogin in severe community-acquired pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• tifacogin

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Pneumonia | Phase 3 | Status: COMPLETED